m6A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD

Xu, Feng; Huang, Xiaoling; Li, Yangyi; Chen, Yongsong; Lin, Ling

doi:10.1016/j.omtn.2021.04.003

Public

m6A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD

Published in Molecular Therapy — Nucleic Acids • Apr 8, 2021

Authors:

Feng Xu

Xiaoling Huang

Yangyi Li

Abstract

Lung adenocarcinoma (LUAD) is the most frequent subtype of lung cancer worldwide. However, the survival rate of LUAD patients remains low. N6-methyladenosine (m 6 A) and long noncoding RNAs (lncRNAs) play vital roles in the prognostic value and the immunotherapeutic response of LUAD. Thus, discernin...

Subject

Immune system

Immune escape

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!